Abbott Alinity ci-series System Control Module software version 2.5.1 recall — FDA Z-1316-2019
Potential performance issues in the Alinity-ci software version 2.5.1
Complete FDA and NHTSA recall records dated in 2019, organized for browsing by month, category and recalling company.
Select a month to review the recall records reported during that period.
Records are ordered by the best available source date.
Potential performance issues in the Alinity-ci software version 2.5.1
Devices were delivered without the required dry ice.
Patient results may be falsely elevated. This patient impact only applies to patients currently being treated with or recently treated with the drug Mifepristone.
In affected Artis systems the movement of the floating tabletop may be blocked after a collision sensor has been activated during system movement.
Tissu-Trans FILTRON 2000, Catalog 3-TT-FILTRON 2000, sterile, disposable, one-patient use. The firm name on the label is Shippert Medical Technologies, Centennial, CO.
Background calibration has the potential to cause false positive or false negative test results. An incorrect test result with the BD Veritor System could lead to possible misdiagnosis and…
Incorrect default dose and dose increments may be transmitted to the controller if the catheter RFID tag is not correct or is not being correctly or completely readable by the controller.
May show diminished performance prior to its established expiration date resulting in an invalid control result for the KTOll GNR PNA FISH Test
The firm has received 7 reports of malfunction for the device in which the hooks have broken off, potentially leading the sling to slip out of the sling bar and causing the patient to fall.
Devices were delivered without the required dry ice.
System software inhibits the monitor and as a result does not measure, display and alarm for pulse rates above 240 beats per minute.
The staplers may have an insufficient firing stroke to break the washer and completely form staples.
Devices were delivered without the required dry ice.
The staplers may have an insufficient firing stroke to break the washer and completely form staples.
The pouch integrity of the sterile product can't be assured without a visual examination due to possibly containing a cut or hole in the pouch.
Devices were delivered without the required dry ice.
The staplers may have an insufficient firing stroke to break the washer and completely form staples.
Product design change did not receive proper premarket clearance and lacks a 510 (k)
Product recalled due to potential for contamination with Listeria monocytogenes.
Barlean's dietary supplement product is recalled due to undeclared Sulfites. Sulfite levels of finished goods does not exceed 10 ppm.
Dried spice and herb products potentially contaminated with generic E. coli.
Barlean's dietary supplement product is recalled due to undeclared Sulfites. Sulfite levels of finished goods does not exceed 10 ppm.
The product contains almonds which are not declared on the label. Instead, pecans are declared on the label but is not an ingredient in the product.
Barlean's dietary supplement product is recalled due to undeclared Sulfites. Sulfite levels of finished goods does not exceed 10 ppm.
This archive groups records by their reported or recall date. It does not imply that every recall was initiated, announced and resolved during the same calendar year. Open the individual record for the exact dates and source details supplied by FDA or NHTSA.